{'fraction_non_alphanumeric': 0.0686427457098284, 'fraction_numerical': 0.054602184087363496, 'mean_word_length': 4.305785123966942, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Crump M, Neelapu SS, Farooq U, et al. Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study. Blood. 2017;130(16):1800-1808.

In Table 1 on page 1803 in the 19 October 2017 issue, there are errors in the row labeled “Indeterminate/missing.” Also, the footnote symbol “‡” should be added to the row heading “Total no. of lines of chemotherapy and ASCT received, %” and corresponding text should be added as is shown in the corrected footnote. The row’s subheading “2” should read “2-3” and the subheading “3” should read “$4.” The last row should be deleted. The corrected Table 1 is shown below.